Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1961 1
1963 2
1964 1
1966 3
1967 10
1968 5
1969 2
1970 4
1971 2
1972 2
1973 3
1974 1
1975 3
1976 1
1977 3
1978 1
1980 1
1981 1
1982 1
1983 2
1984 5
1985 4
1986 2
1987 3
1989 1
1990 5
1991 2
1993 2
1994 3
1995 1
1996 2
1997 2
1999 1
2001 2
2003 3
2004 2
2006 4
2007 5
2008 4
2009 4
2011 3
2012 4
2013 7
2014 9
2015 7
2016 1
2017 6
2018 5
2019 8
2020 2
2021 9
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

157 results
Results by year
Filters applied: . Clear all
Page 1
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia.
DiNardo CD, Pratz K, Pullarkat V, Jonas BA, Arellano M, Becker PS, Frankfurt O, Konopleva M, Wei AH, Kantarjian HM, Xu T, Hong WJ, Chyla B, Potluri J, Pollyea DA, Letai A. DiNardo CD, et al. Among authors: frankfurt o. Blood. 2019 Jan 3;133(1):7-17. doi: 10.1182/blood-2018-08-868752. Epub 2018 Oct 25. Blood. 2019. PMID: 30361262 Free PMC article.
Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia.
DiNardo CD, Stein AS, Stein EM, Fathi AT, Frankfurt O, Schuh AC, Döhner H, Martinelli G, Patel PA, Raffoux E, Tan P, Zeidan AM, de Botton S, Kantarjian HM, Stone RM, Frattini MG, Lersch F, Gong J, Gianolio DA, Zhang V, Franovic A, Fan B, Goldwasser M, Daigle S, Choe S, Wu B, Winkler T, Vyas P. DiNardo CD, et al. Among authors: frankfurt o. J Clin Oncol. 2021 Jan 1;39(1):57-65. doi: 10.1200/JCO.20.01632. Epub 2020 Oct 29. J Clin Oncol. 2021. PMID: 33119479 Free PMC article. Clinical Trial.
Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study.
Horwitz ME, Stiff PJ, Cutler C, Brunstein C, Hanna R, Maziarz RT, Rezvani AR, Karris NA, McGuirk J, Valcarcel D, Schiller GJ, Lindemans CA, Hwang WYK, Koh LP, Keating A, Khaled Y, Hamerschlak N, Frankfurt O, Peled T, Segalovich I, Blackwell B, Wease S, Freedman LS, Galamidi-Cohen E, Sanz G. Horwitz ME, et al. Among authors: frankfurt o. Blood. 2021 Oct 21;138(16):1429-1440. doi: 10.1182/blood.2021011719. Blood. 2021. PMID: 34157093 Clinical Trial.
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors.
Numan Y, Abdel Rahman Z, Grenet J, Boisclair S, Bewersdorf JP, Collins C, Barth D, Fraga M, Bixby DL, Zeidan AM, Yilmaz M, Desai P, Mannis G, Deutsch YE, Abaza Y, Dinner S, Frankfurt O, Litzow M, Al-Kali A, Foran JM, Sproat LZ, Jovanovic B, Daver N, Perl AE, Altman JK. Numan Y, et al. Among authors: frankfurt o. Am J Hematol. 2022 Mar 1;97(3):322-328. doi: 10.1002/ajh.26447. Epub 2022 Jan 7. Am J Hematol. 2022. PMID: 34981560 Clinical Trial.
Growth factors in leukemia.
Frankfurt O, Tallman MS. Frankfurt O, et al. J Natl Compr Canc Netw. 2007 Feb;5(2):203-15. doi: 10.6004/jnccn.2007.0020. J Natl Compr Canc Netw. 2007. PMID: 17335689 Review.
Impact of race on outcomes in intermediate-risk acute myeloid leukemia.
Abraham IE, Patel AA, Wang H, Galvin JP, Frankfurt O, Liu L, Khan I. Abraham IE, et al. Among authors: frankfurt o. Cancer Causes Control. 2021 Jul;32(7):705-712. doi: 10.1007/s10552-021-01422-4. Epub 2021 Apr 9. Cancer Causes Control. 2021. PMID: 33837498
Acute lymphoblastic leukemia.
Alvarnas JC, Brown PA, Aoun P, Ballen KK, Bellam N, Blum W, Boyer MW, Carraway HE, Coccia PF, Coutre SE, Cultrera J, Damon LE, DeAngelo DJ, Douer D, Frangoul H, Frankfurt O, Goorha S, Millenson MM, O'Brien S, Petersdorf SH, Rao AV, Terezakis S, Uy G, Wetzler M, Zelenetz AD, Naganuma M, Gregory KM; National Comprehensive Cancer Network. Alvarnas JC, et al. Among authors: frankfurt o. J Natl Compr Canc Netw. 2012 Jul 1;10(7):858-914. doi: 10.6004/jnccn.2012.0089. J Natl Compr Canc Netw. 2012. PMID: 22773801
Myelodysplastic syndromes, version 2.2015.
Greenberg PL, Stone RM, Bejar R, Bennett JM, Bloomfield CD, Borate U, De Castro CM, Deeg HJ, DeZern AE, Fathi AT, Frankfurt O, Gaensler K, Garcia-Manero G, Griffiths EA, Head D, Klimek V, Komrokji R, Kujawski LA, Maness LJ, O'Donnell MR, Pollyea DA, Scott B, Shami PJ, Stein BL, Westervelt P, Wheeler B, Shead DA, Smith C; National comprehensive cancer network. Greenberg PL, et al. Among authors: frankfurt o. J Natl Compr Canc Netw. 2015 Mar;13(3):261-72. doi: 10.6004/jnccn.2015.0038. J Natl Compr Canc Netw. 2015. PMID: 25736003 Free PMC article.
The coagulopathy of acute promyelocytic leukaemia revisited.
Stein E, McMahon B, Kwaan H, Altman JK, Frankfurt O, Tallman MS. Stein E, et al. Among authors: frankfurt o. Best Pract Res Clin Haematol. 2009 Mar;22(1):153-63. doi: 10.1016/j.beha.2008.12.007. Best Pract Res Clin Haematol. 2009. PMID: 19285282 Review.
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.
Zeidner JF, Lin TL, Vigil CE, Fine G, Yair Levy M, Nazha A, Esteve J, Lee DJ, Yee K, Dalovisio A, Wang ES, Bergua Burgues JM, Schriber J, Litzow MR, Frankfurt O, Castillo TBD, Bhatt VR, Bhatnagar B, Mehta P, Dillon R, Vicente MV, Anthony S, Bearss D, Montesinos P, Douglas Smith B. Zeidner JF, et al. Among authors: frankfurt o. Blood Cancer J. 2021 Oct 30;11(10):175. doi: 10.1038/s41408-021-00568-3. Blood Cancer J. 2021. PMID: 34718324 Free PMC article. Clinical Trial. No abstract available.
157 results